Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Momelotinib (sulfate)

Momelotinib sulfate (CYT387 sulfate salt) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/18 nM, 10-fold selectivity versus JAK3 (IC50=155 nM) .

Product Specifications

CAS Number

[1056636-06-6]

Product Name Alternative

CYT387 (sulfate salt)

UNSPSC

12352005

Target

Apoptosis; Autophagy; JAK

Type

Reference compound

Related Pathways

Apoptosis; Autophagy; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/CYT387-sulfate-salt.html

Purity

99.91

Solubility

DMSO : 220 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)

Smiles

O=C(NCC#N)C(C=C1)=CC=C1C2=NC(NC(C=C3)=CC=C3N4CCOCC4)=NC=C2.O=S(O)(O)=O.O=S(O)(O)=O

Molecular Formula

C23H26N6O10S2

Molecular Weight

610.62

References & Citations

[1]Pardanani A, et al. CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients. Leukemia, 2009, 23 (8), 1441-1445.|[2]Tyner JW, et al. CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms. Blood, 2010, 115 (25), 5232-5240.|[3]Burns CJ, et al. Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs) . Bioorg Med Chem Lett. 2009 Oct 15;19 (20) :5887-92.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-10962/Momelotinib-sulfate-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-10962/Momelotinib-sulfate-SDS-MedChemExpress.pdf

Scientific Category

Reference compound1

Clinical Information

Phase 3

Isoform

JAK1; JAK2; JAK3

Citation 01

Harvard Medical School LINCS LIBRARY|BANGL J PHARMACOL. 2025 Apr 10;197 (5) :533.|bioRxiv. 2025 Oct 25.|Cancer Cell. 2018 Sep 10;34 (3) :439-452.e6. |Cancer Immunol Res. 2016 Jun;4 (6) :520-30.|Cancer Res. 2020 Jan 1;80 (1) :44-56. |Cell Death Dis. 2022 Dec 27;13 (12) :1075.|Cell Syst. 2018 Apr 25;6 (4) :424-443.e7.|Harvard Medical School LINCS LIBRARY|Immunol Invest. 2022 Aug;51 (6) :1582-1597.|Int J Biol Sci. 2022 Jan 1;18 (2) :585-598.|J Biotechnol. 2025 Mar:399:9-18.|J Enzyme Inhib Med Chem. 2025 Dec;40 (1) :2488127.|J Pineal Res. 2019 Apr;66 (3) :e12552.|Leukemia. 2012 Oct;26 (10) :2233-44.|Metabolism. 2025 Apr 4:156259.|Nat Commun. 2025 Jul 24;16 (1) :6777.|Sci Transl Med. 2018 Jul 18;10 (450) :eaaq1093.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Abeta40 polyclonal rabbit antiserum
218 202 200 µL

Abeta40 polyclonal rabbit antiserum

Ask
View Details
CE3F4 analog 1
MBS5802724 Inquire

CE3F4 analog 1

Ask
View Details
ASMT Human
PT-A00330-01 5 µg

ASMT Human

Ask
View Details
ASMT Human
PT-A00330-02 20 µg

ASMT Human

Ask
View Details
ASMT Human
PT-A00330-03 1 mg

ASMT Human

Ask
View Details
FKBP5 (FKBP51) mouse monoclonal antibody
MB4160-01 25 µL

FKBP5 (FKBP51) mouse monoclonal antibody

Ask
View Details